Related Experiment Video
Updated: Aug 11, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
Published on: May 30, 2025
Comparison between sildenafil-treated subjects with erectile dysfunction and control subjects on the Self-Esteem And
Joseph C Cappelleri1, Stephen S Bell, Stanley E Althof
1Pfizer Inc, Global Research & Development, Groton, CT 06340, USA. joseph.c.cappelleri@pfizer.com
Introduction:
Erectile dysfunction (ED) can negatively impact psychosocial measures of a patient's sexual life.
Aim:
To evaluate self-esteem, confidence, and relationships in men with ED, before and after treatment with sildenafil citrate (Viagra), with reference to controls without ED.
Methods:
Sildenafil-naïve patients with ED were enrolled in a 10-week, open-label, flexible-dose (25 mg, 50 mg, or 100 mg) trial of sildenafil. In a separate study, men without ED who did not take sildenafil also completed the Self-Esteem And Relationship (SEAR) questionnaire. In addition to traditional statistical testing, equivalency testing was applied to compare the ED group, before and after treatment, with the control group and to examine whether the ED group improved to normative ranges on the SEAR questionnaire after treatment (within half a standard deviation of the normative or control group mean).
Main Outcome Measures:
Baseline and end-of-treatment responses on psychosocial aspects of ED were measured with the validated SEAR.
Results:
Mean SEAR scores between subjects with ED (N = 93, mean age 55.0 years) at baseline and control subjects without ED (N = 94, mean age 52.5 years) were statistically different from zero and not statistically equivalent. Conversely, mean SEAR scores between ED subjects after treatment and control subjects were statistically equivalent and not statistically different from zero.
Conclusions:
The results indicate that sildenafil is associated with normalization of relationships, confidence, and self-esteem in men with ED.
Related Concept Videos
Self-Discrepancy Theory
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Sources of Self-Esteem III: Social Comparison
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Benefits of Self-Esteem
Self-Esteem